SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBank Irel13.375 Regulatory News (BOI)

Share Price Information for Bank Irel13.375 (BOI)

Share Price is delayed by 15 minutes
Get Live Data
188.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
BOI Live PriceLast checked at - London Stock Exchange

Intraday Bank Irel13.375 Share Chart

Statement re Possible Offer

15 Sep 2006 07:55

Biotrace International PLC15 September 2006 15 September 2006 STATEMENT REGARDING RECENT PRESS SPECULATION The Board of Biotrace International PLC (the "Company") notes the recent pressspeculation regarding a potential offer for the Company and confirms that it hasreceived a number of preliminary approaches, which may or may not lead to anoffer being made for the Company. A further announcement will be made in due course. Enquiries: Telephone Biotrace International plc +44 (0)1656 641 400Ian Johnson Numis Securities Limited +44 (0)20 7776 1500Michael MeadeBruce Garrow Dealing disclosure requirements Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the"Code"), if any person is, or becomes, "interested" (directly or indirectly) in1% or more of any class of "relevant securities" of the Company, all "dealings"in any "relevant securities" of the Company (including by means of an option inrespect of, or a derivative referenced to, any such "relevant securities") mustbe publicly disclosed by no later than 3.30pm (London time) on the Londonbusiness day following the date of the relevant transaction. This requirementwill continue until the date on which the offer becomes, or is declared,unconditional as to acceptances, lapses or is otherwise withdrawn or on whichthe "offer period" otherwise ends. If two or more persons act together pursuantto an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of the Company, they will be deemed to be asingle person for the purpose of Rule 8.3. Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevantsecurities" of the Company by an offeror or the Company, or by any of theirrespective "associates", must be disclosed by no later than 12.00 noon (Londontime) on the London business day following the date of the relevant transaction. A disclosure table, giving details of the companies in whose "relevantsecurities" "dealings" should be disclosed, and the number of such securities inissue, can be found on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. "Interests in securities" arise, in summary, when a person has a long economicexposure, whether conditional or absolute, to changes in the price ofsecurities. In particular, a person will be treated as having an "interest" byvirtue of the ownership or control of securities, or by virtue of any option inrespect of, or derivative referenced to, securities. Terms in quotation marks are defined in the Code, which can also be found on thePanel's website. If you are in any doubt as to whether or not you are requiredto disclose a "dealing" under Rule 8, you should consult the Panel. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Oct 20067:00 amRNSRule 8.3- Biotrace Int.
10th Oct 200610:31 amRNSEPT Disclosure
10th Oct 20067:00 amRNSRule 8.3- Biotrace Int.
9th Oct 20061:30 pmRNSRule 8.3 - Biotrace Int.
9th Oct 200610:49 amRNSEPT Disclosure
6th Oct 20065:59 pmRNSRule 8.1- Biotrace Intl-Amend
6th Oct 20061:26 pmRNSRule 8.3- Biotrace Intl. Plc
6th Oct 200611:54 amRNSEPT Disclosure
6th Oct 200611:00 amRNSEPT Disclosure
6th Oct 200610:58 amRNSEPT Disclosure
6th Oct 200610:55 amRNSOffer Update
6th Oct 200610:52 amRNSRule 8.1- Biotrace Int. PLC
6th Oct 20067:00 amRNSRule 8.3 - Biotrace Int.
5th Oct 200610:26 amRNSEPT Disclosure
4th Oct 20065:34 pmRNSOffer for Biotrace Intl PLC
26th Sep 200610:26 amRNSEPT Disclosure
25th Sep 200610:11 amRNSEPT Disclosure
22nd Sep 200610:38 amRNSEPT Disclosure - Amendment
21st Sep 200610:46 amRNSEPT Disclosure
20th Sep 200610:47 amRNSEPT Disclosure
19th Sep 200610:44 amRNSEPT Disclosure
18th Sep 200611:14 amRNSEPT Disclosure
15th Sep 20068:08 amRNSRule 2.10 Announcement
15th Sep 20067:55 amRNSStatement re Possible Offer
12th Sep 20064:38 pmRNSHolding(s) in Company
6th Sep 20067:01 amRNSInterim Results
14th Aug 20064:25 pmRNSAnnual Information Update
8th Aug 200612:18 pmRNSAnnual Information Update
1st Aug 20067:01 amRNSDirectorate Change
20th Jul 20067:01 amRNSTrading Update
31st May 20067:04 amRNSFinal Results
24th May 200610:23 amRNSHolding(s) in Company
18th May 200612:34 pmRNSHolding(s) in Company
15th May 20067:01 amRNSHolding(s) in Company
11th May 20061:58 pmRNSHolding(s) in Company
11th May 200611:36 amRNSResult of AGM
11th May 20068:02 amRNSAGM Statement
11th May 20067:01 amRNSAGM Statement
11th May 20067:01 amRNSNew Contract
10th May 20062:29 pmRNSAnnual Information Update
21st Apr 20067:00 amRNSCompletion of Property Sale
13th Apr 20065:26 pmRNSHolding(s) in Company
3rd Apr 20067:01 amRNSProperty Disposal
28th Mar 20068:43 amRNSNotifiable Interest
9th Mar 200612:37 pmRNSBlocklisting 6 Monthly Return
8th Mar 20067:04 amRNSAcquisition
1st Mar 20067:02 amRNSPreliminary Results
9th Feb 20067:01 amRNSDisposal of Ruskinn
6th Feb 20061:53 pmRNSHolding(s) in Company
30th Jan 200612:00 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.